News

11 october 21

PRO-GLIO - Håper ny studie kan gi svar om protonterapi

There is little research on the effect of proton therapy compared to regular radiation therapy. Soon, Norwegian brain cancer patients can participate in a study that can hopefully provide some more answers.

Interview in norwegian with researcher and oncologist Petter Brandal about the planned PRO-GLIO study.

21 september 21

Instagram: kreftforskning_ous

Department of Clinical Cancer Research is now on Instagram! Here we plan to publish news and show our work day.

Follow us @ kreftforskning_ous

21 september 20

Interview with Head of Department of Experimental Cancer Jon Amund Kyte by Pharma Boardroom 

Oncologist Jon Amund Kyte shares some of the groundbreaking immunotherapy research that he and his team is conducting at Oslo University Hospital. Kyte also explores how Norway can better develop its clinical footprint and what his hopes for the future of experimental cancer treatment in the country are.

15 september 20

BM7PE - New study for colorectal cancer open for inclusion at OUS, Radiumhospitalet

A phase I/II study with BM7PE immunotoxin in colorectal cancer patients with metastactic  disease who are refractory to or with intolerance to last line of standard chemotherapy.